This Drugmakers Parkinsons Medication Just Cleared A Key Hurdle Is It Primed For A Monster Year In 2025?
| JGSRX Fund | USD 12.03 0.32 2.59% |
Slightly above 61% of John Hancock's investor base is looking to short. The analysis of overall sentiment of trading John Hancock Global mutual fund suggests that many investors are alarmed at this time. John Hancock's investing sentiment can be driven by a variety of factors including economic data, John Hancock's earnings reports, geopolitical events, and overall market trends.
John |
Meta-Description Drugmaker AbbVie could be set up for a big year in 2025 after completing another successful clinical trial for its Parkinsons medication. Biotech firms live and die on the success of the medications they develop and clinical testing ...
Read at finance.yahoo.com
 |
John Hancock Fundamental Analysis
We analyze John Hancock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of John Hancock using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of John Hancock based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
John Hancock is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
John Hancock Global Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with John Hancock mutual fund to make a market-neutral strategy. Peer analysis of John Hancock could also be used in its relative valuation, which is a method of valuing John Hancock by comparing valuation metrics with similar companies.
Peers
John Hancock Related Equities
| JRETX | J Hancock | 0.55 |
| ||
| JQLAX | Multimanager Lifestyle | 0.59 |
| ||
| JQLCX | Multimanager Lifestyle | 0.92 |
| ||
| JQLMX | Multimanager Lifestyle | 1.35 |
| ||
| JRBFX | Regional Bank | 1.88 |
| ||
| JQLBX | Multimanager Lifestyle | 1.89 |
| ||
| FRBCX | Regional Bank | 1.90 |
| ||
| FRBAX | Regional Bank | 1.91 |
| ||
| JRGRX | Regional Bank | 1.91 |
| ||
| JQLGX | Multimanager Lifestyle | 2.39 |
|
Other Information on Investing in John Mutual Fund
John Hancock financial ratios help investors to determine whether John Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in John with respect to the benefits of owning John Hancock security.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |